Passage BIO (PASG) Accumulated Depreciation (2020 - 2026)

Passage BIO's Accumulated Depreciation history runs 7 years deep, the most recent figure standing at $2.1 million for Q1 2026.

• In Q1 2026, Accumulated Depreciation fell 39.06% year-over-year to $2.1 million; the TTM figure through Mar 2026 stood at $2.1 million (down 39.06% YoY), while the FY2025 annual figure was $3.9 million, down 59.72% from the prior year.
• Accumulated Depreciation for Q1 2026 stood at $2.1 million, down from $3.9 million in the prior quarter.
• The five-year high for Accumulated Depreciation was $9.7 million in Q4 2024, with the low at $2.1 million in Q1 2026.
• The 5-year median for Accumulated Depreciation is $5.2 million (2022), against an average of $5.6 million.
• The sharpest annual moves came in 2023 and 2025: Accumulated Depreciation jumped 112.69% in 2023, then plunged 59.72% in 2025.
• Passage BIO's Accumulated Depreciation stood at $5.2 million in 2022, then soared by 40.42% to $7.2 million in 2023, then soared by 34.38% to $9.7 million in 2024, then tumbled by 59.72% to $3.9 million in 2025, then plunged by 47.46% to $2.1 million in 2026.
• Business Quant data shows PASG's Accumulated Depreciation at $2.1 million in Q1 2026, $3.9 million in Q4 2025, and $3.7 million in Q3 2025.